{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:32:18Z","timestamp":1791685938411,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Framework 7","award":["281654"],"award-info":[{"award-number":["281654"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ejps.2018.01.009","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T18:09:20Z","timestamp":1515175760000},"page":"57-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Development and applications of a physiologically-based model of paediatric oral drug absorption"],"prefix":"10.1016","volume":"115","author":[{"given":"T.N.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.T.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.01.009_bb0005","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.clinthera.2012.09.014","article-title":"Summary of the National Institute of Child Health and Human Development-Best Pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System working group","volume":"34","author":"Abdel-Rehman","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2018.01.009_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.01.009_bb0015","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/00000542-200206000-00012","article-title":"Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis","volume":"96","author":"Anderson","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2018.01.009_bb0020","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1542\/peds.37.6.1005","article-title":"Gastric acidity in the first day of life","volume":"37","author":"Avery","year":"1966","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejps.2018.01.009_bb0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-3476(52)80176-3","article-title":"Investigations on the bacterial flora, pH, and sugar content in the intestinal tract of infants","volume":"40","author":"Barbero","year":"1952","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejps.2018.01.009_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2014.02.046","article-title":"Paediatric biopharmaceutics classification system: current status and future decisions","volume":"469","author":"Batchelor","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.01.009_bb0035","series-title":"Paediatric Formulations: A Roadmap","first-page":"43","article-title":"Paediatric development: gastrointestinal","author":"Batchelor","year":"2014"},{"key":"10.1016\/j.ejps.2018.01.009_bb0040","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ejpb.2013.04.015","article-title":"Application of in vitro biopharmaceutical methods in development of immediate release oral dosage forms intended for paediatric patients","volume":"85","author":"Batchelor","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2018.01.009_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2013.10.006","article-title":"Paediatric oral biopharmaceutics: key considerations and current challenges","volume":"73","author":"Batchelor","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.01.009_bb0050","article-title":"Food effects in paediatric medicines development for products Co-administered with food","author":"Batchelor","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.01.009_bb0055","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/jps.20073","article-title":"Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination","volume":"93","author":"Berezhkovskiy","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.01.009_bb0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bdd.1937","article-title":"Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults","volume":"36","author":"Bonner","year":"2015","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2125.1983.tb01521.x","article-title":"Determinants of the plasma protein binding of theophylline in health","volume":"15","author":"Buss","year":"1983","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.01.009_bb0070","first-page":"1334","article-title":"Effect of pH on disintegration and dissolution of ketoconazole tablets","volume":"40","author":"Carlson","year":"1983","journal-title":"Am. J. Hosp. Pharm."},{"key":"10.1016\/j.ejps.2018.01.009_bb0075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1124\/dmd.110.035147","article-title":"Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450","volume":"39","author":"Chen","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0080","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1213\/00000539-199010000-00014","article-title":"Effects of duration of fasting on gastric fluid pH and volume in healthy children","volume":"71","author":"Crawford","year":"1990","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejps.2018.01.009_bb0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/bdd.760","article-title":"Are there differences in the catalytic activity per unit enzyme of recombinantly expressed and human liver microsomal cytochrome P450 2C9? A systematic investigation into inter-system extrapolation factors","volume":"32","author":"Crewe","year":"2011","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0090","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.xphs.2016.01.027","article-title":"Exploratory investigation of the limiting steps of oral absorption of fluconazole and ketoconazole in children using an in silico pediatric absorption model","volume":"105","author":"Cristofoletti","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.01.009_bb0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00003088-198814010-00002","article-title":"Clinical pharmacokinetics of ketoconazole","volume":"14","author":"Daneshmend","year":"1988","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2018.01.009_bb0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/12.2.185","article-title":"Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man","volume":"12","author":"Daneshmend","year":"1983","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejps.2018.01.009_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.25.1.1","article-title":"Influence of food on the pharmacokinetics of ketoconazole","volume":"25","author":"Daneshmend","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.01.009_bb0110","series-title":"Therapeutic Drugs","author":"Dollery","year":"1999"},{"key":"10.1016\/j.ejps.2018.01.009_bb0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1289\/ehp.0800073","article-title":"Predicting plasma concentrations of bisphenol A in children younger than 2years of age after typical feeding schedules, using a physiologically based toxicokinetic model","volume":"117","author":"Edginton","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ejps.2018.01.009_bb0120","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1124\/dmd.105.005611","article-title":"Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age","volume":"33","author":"Fakhoury","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1365-2036.1989.tb00254.x","article-title":"pH-profile and regional transit times of the normal gut measured by a radiotelemetry device","volume":"3","author":"Fallingborg","year":"1989","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.01.009_bb0130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1208\/s12249-014-0084-0","article-title":"Considerations for a pediatric biopharmaceutics classification system (BCS): application to five drugs","volume":"15","author":"Gandhi","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2018.01.009_bb0135","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1128\/AAC.23.5.787","article-title":"Pharmacology of ketoconazole suspension in infants and children","volume":"23","author":"Ginsburg","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.01.009_bb0140","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/00000542-198111000-00009","article-title":"The dose-response effects of oral cimetidine on gastric pH and volume in children","volume":"55","author":"Goudsouzian","year":"1981","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejps.2018.01.009_bb0145","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1378\/chest.92.1.129","article-title":"Evaluation of whole blood theophylline enzyme immunochromatography assay","volume":"92","author":"Habib","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.ejps.2018.01.009_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-4274(95)03356-P","article-title":"The expanding role of quantitative structure-activity relationships (QSAR) in toxicology","volume":"79","author":"Hansch","year":"1995","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2018.01.009_bb0155","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000240105","article-title":"The acidity of the gastric contents of premature babies during the first fourteen days of life","volume":"12","author":"Harries","year":"1968","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.ejps.2018.01.009_bb0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/bdd.2062","article-title":"Quantifying gut wall metabolism: methodology matters","volume":"38","author":"Hatley","year":"2017","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00561477","article-title":"Enteral absorption and bioavailability in children in relation to age","volume":"18","author":"Heimann","year":"1980","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.01.009_bb0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00542463","article-title":"Influence of food intake on bioavailability of theophylline in premature infants","volume":"22","author":"Heimann","year":"1982","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.01.009_bb0175","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/adc.65.9.971","article-title":"Pharmacokinetics of paracetamol after cardiac surgery","volume":"65","author":"Hopkins","year":"1990","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejps.2018.01.009_bb0180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1128\/AAC.30.2.206","article-title":"Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers","volume":"30","author":"Huang","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejps.2018.01.009_bb0185","first-page":"116","article-title":"Basic anatomical and physiological data for use in radiological protection: reference values","volume":"32","author":"ICRP","year":"2002","journal-title":"Ann. ICRP"},{"key":"10.1016\/j.ejps.2018.01.009_bb0190","first-page":"5","article-title":"Basic anatomical and physiological data for use in radiological protection: reference values. A report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP publication 89","volume":"32","author":"ICRP","year":"2002","journal-title":"Ann. ICRP"},{"key":"10.1016\/j.ejps.2018.01.009_bb0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2018.01.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.55","article-title":"Application of physiologically based pharmacokinetic modeling to predict acetaminophen metabolism and pharmacokinetics in children","volume":"2","author":"Jiang","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2018.01.009_bb0205","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2125.2001.01370.x","article-title":"Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis","volume":"51","author":"Johnson","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.01.009_bb0210","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00003088-200645090-00005","article-title":"Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children","volume":"45","author":"Johnson","year":"2006","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2018.01.009_bb0215","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/bdd.1899","article-title":"Development of physiologically based pharmacokinetic model to evaluate the relative systemic exposure to quetiapine after administration of IR and XR formulations to adults, children and adolescents","volume":"35","author":"Johnson","year":"2014","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0220","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1208\/s12248-013-9555-6","article-title":"Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug","volume":"16","author":"Khalil","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2018.01.009_bb0225","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/clinchem\/14.5.477","article-title":"Duodenal fluid pH in cystic fibrosis","volume":"14","author":"Knauff","year":"1968","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejps.2018.01.009_bb0230","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1208\/s12248-017-0149-6","article-title":"Investigating oral absorption of carbamazepine in pediatric populations","volume":"19","author":"Kohlmann","year":"2017","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2018.01.009_bb0235","first-page":"588","article-title":"Theophylline pharmacokinetics in well-nourished and malnourished asthmatic children","volume":"27","author":"Kumar","year":"1989","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.ejps.2018.01.009_bb0240","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/clpt.2012.19","article-title":"Regulatory experience with physiologically based pharmacokinetic modeling for pediatric drug trials","volume":"91","author":"Leong","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.01.009_bb0245","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.xphs.2016.06.026","article-title":"A physiologically based pharmacokinetic model to describe Artemether pharmacokinetics in adult and pediatric patients","volume":"105","author":"Lin","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.01.009_bb0250","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/bdd.2510100606","article-title":"Lack of effect of co-trimoxazole on the pharmacokinetics of orally administered theophylline","volume":"10","author":"Lo","year":"1989","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0255","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/gut.16.9.719","article-title":"Gastric pH and microflora of normal and diarrhoeic infants","volume":"16","author":"Maffei","year":"1975","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2018.01.009_bb0260","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/dmd.115.068700","article-title":"Examining small intestinal transit time as a function of age: is there evidence to support age-dependent differences among children?","volume":"44","author":"Maharaj","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0265","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11095-015-1762-7","article-title":"Assessment of age-related changes in pediatric gastrointestinal solubility","volume":"33","author":"Maharaj","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.01.009_bb0270","first-page":"271","article-title":"Serum binding of ketoconazole in health and disease","volume":"10","author":"Martinez-Jorda","year":"1990","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"10.1016\/j.ejps.2018.01.009_bb0275","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/adc.37.194.387","article-title":"Some aspects of gastric function in the newborn","volume":"37","author":"Mason","year":"1962","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejps.2018.01.009_bb0280","first-page":"204","article-title":"Pediatric fluid and electrolyte therapy","volume":"14","author":"Meyers","year":"2009","journal-title":"J. Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.01.009_bb0285","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-3476(88)80192-6","article-title":"Furosemide pharmacokinetics in very low birth weight infants","volume":"112","author":"Mirochnick","year":"1988","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejps.2018.01.009_bb0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/adc.84.3.273","article-title":"Simultaneous monitoring of gastric and oesophageal pH reveals limitations of conventional oesophageal pH monitoring in milk fed infants","volume":"84","author":"Mitchell","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejps.2018.01.009_bb0295","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/bcp.12211","article-title":"Developmental trajectory of intestinal MDR1\/ABCB1 mRNA expression in children","volume":"77","author":"Mizuno","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.01.009_bb0300","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1124\/dmd.114.056929","article-title":"Ontogeny of human hepatic and intestinal transporter gene expression during childhood: age matters","volume":"42","author":"Mooij","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0305","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm405","article-title":"Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1","volume":"5","author":"Nies","year":"2013","journal-title":"Genome Med."},{"key":"10.1016\/j.ejps.2018.01.009_bb0310","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/bdd.2072","article-title":"Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon","volume":"38","author":"Pade","year":"2017","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.ejps.2018.01.009_bb0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0009-9236(96)90162-9","article-title":"First-pass metabolism of midazolam by the human intestine","volume":"60","author":"Paine","year":"1996","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.01.009_bb0320","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1021\/acs.molpharmaceut.7b00406","article-title":"Model-based analysis of biopharmaceutical experiments to improve mechanistic oral absorption modelling - an integrated in vitro in vivo extrapolation (IVIVE) perspective using ketoconazole as a model drug","volume":"14","author":"Pathak","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2018.01.009_bb0325","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jps.10005","article-title":"Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution","volume":"91","author":"Poulin","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.01.009_bb0330","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1007\/s11095-012-0844-z","article-title":"An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine","volume":"29","author":"Psachoulias","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.01.009_bb0335","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00007691-199702000-00010","article-title":"Griseofulvin and fluvoxamine interactions with the metabolism of theophylline","volume":"19","author":"Rasmussen","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ejps.2018.01.009_bb0340","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/jps.20502","article-title":"Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions","volume":"95","author":"Rodgers","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.01.009_bb0345","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejps.2009.12.002","volume":"39","author":"Rowland Yeo","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.01.009_bb0350","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/bja\/aeu399","article-title":"Gastric pH and residual volume after 1 and 2h fasting time for clear fluids in childrendagger","volume":"114","author":"Schmidt","year":"2015","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejps.2018.01.009_bb0355","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1213\/00000539-199810000-00003","article-title":"Gastric contents in children presenting for upper endoscopy","volume":"87","author":"Schwartz","year":"1998","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejps.2018.01.009_bb0360","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bcp.12752","article-title":"Evaluation of changes in oral drug absorption in preterm and term neonates for biopharmaceutics classification system (BCS) class I and II compounds","volume":"81","author":"Somani","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.01.009_bb0365","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00005176-198506000-00005","article-title":"Continuous gastric pH measurement in young and older healthy preterm infants receiving formula and clear liquid feedings","volume":"4","author":"Sondheimer","year":"1985","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ejps.2018.01.009_bb0370","first-page":"522","article-title":"The effect of gastric pH on the absorption of ketoconazole by very low birth weight infants","volume":"35","author":"van den Anker","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.01.009_bb0375","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1208\/s12248-016-9896-z","article-title":"Using physiologically based pharmacokinetic (PBPK) modelling to gain insights into the effect of physiological factors on oral absorption in paediatric populations","volume":"18","author":"Villiger","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2018.01.009_bb0380","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.clinthera.2012.12.016","article-title":"Pharmacokinetic comparison of acetaminophen elixir versus suppositories in vaccinated infants (aged 3 to 36months): a single-dose, open-label, randomized, parallel-group design","volume":"35","author":"Walson","year":"2013","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2018.01.009_bb0385","series-title":"Complimentary Feeding, Infant and Young Child Feeding","author":"WHO","year":"2009"},{"key":"10.1016\/j.ejps.2018.01.009_bb0390","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40262-013-0090-5","article-title":"Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban","volume":"53","author":"Willmann","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2018.01.009_bb0395","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.01.009_bb0400","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.clpt.2004.07.001","article-title":"Cytochrome P450 3A expression and activity in the human small intestine","volume":"76","author":"Yang","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.01.009_bb0405","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-2952(95)00120-O","article-title":"Characterization of human cytochromes P450 involved in theophylline 8-hydroxylation","volume":"50","author":"Zhang","year":"1995","journal-title":"Biochem. Pharmacol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718300095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718300095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T21:56:42Z","timestamp":1660255002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718300095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":81,"alternative-id":["S0928098718300095"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.01.009","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and applications of a physiologically-based model of paediatric oral drug absorption","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}